Oxford, United Kingdom

Dasakumar S Navaratnam

This inventor holds 1 USPTO granted patent. Top assignee: E. R. Squibb Sons, Inc.. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dasakumar S Navaratnam. Retrieved from https://idiyas.com/inventor/dasakumar-s-navaratnam

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dasakumar S Navaratnam: Innovator in Alzheimer's Diagnosis

Introduction

Dasakumar S Navaratnam is a notable inventor based in Oxford, GB. He has made significant contributions to the field of medical diagnostics, particularly in the area of Alzheimer's disease. His innovative approach has the potential to enhance the early detection of this debilitating condition.

Latest Patents

Dasakumar holds a patent for a method of diagnosing senile dementia of the Alzheimer type. This method involves screening for an anomalous molecular form of acetylcholinesterase in the cerebrospinal fluid of a patient. This breakthrough could lead to more accurate and timely diagnoses for individuals suffering from Alzheimer's disease. He has 1 patent to his name.

Career Highlights

Currently, Dasakumar is associated with E. R. Squibb Sons, Inc., where he continues to work on innovative solutions in the medical field. His expertise and dedication to research have positioned him as a valuable asset in his organization.

Collaborations

Dasakumar has collaborated with notable colleagues, including John D Priddle and Brendon I McDonald. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Dasakumar S Navaratnam's work in diagnosing Alzheimer's disease exemplifies the impact of innovation in healthcare. His contributions are paving the way for advancements in medical diagnostics, ultimately benefiting patients and healthcare providers alike.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…